+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acadia Pharmaceuticals Inc  - logo

Acadia Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. Its lead product candidate, NUPLAZID, has completed the Phase III pivotal trials for the treatment of Parkinson's disease, Phase II trial for the treatment of schizophrenia and Phase II study for the treatment of Alzheimer's disease. The company was founded in 1993 and is headquartered in San Diego, California.

From
Global Parkinson's Drug Market & Clinical Trial Insight 2025 - Product Thumbnail Image

Global Parkinson's Drug Market & Clinical Trial Insight 2025

  • Clinical Trials
  • January 2020
  • 500 Pages
From
From
From
From
From
Dementia Drugs Market 2020-2026 - Product Thumbnail Image

Dementia Drugs Market 2020-2026

  • Report
  • June 2020
From
From
From
From
From
Parkinson's: Pipeline Assessment and Insights - Product Thumbnail Image

Parkinson's: Pipeline Assessment and Insights

  • Report
  • April 2018
  • 100 Pages
From
Parkinson's: Epidemiology Overview and Insights - Product Thumbnail Image

Parkinson's: Epidemiology Overview and Insights

  • Report
  • April 2018
  • 50 Pages
From
From
From
Lewy body Dementia Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Lewy body Dementia Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • November 2017
  • 57 Pages
From
Loading Indicator
adroll